Nanomedicine News

RSS

New BIONOVA NANO SKIN TECH Solution for Dry Foot and Foot Inflammation

When it comes to beauty care, feet are not the first area to come to mind. The feet experience the most daily stress of wear and tear yet we often forget they need proper care, as well. Dry skin on the feet is the culprit of cracked heels, flakiness, itchiness and a burning sensation, which brings disruptive discomfort for a body area that is always in use.

10 Sep 2013

DNA Nanoparticles Reveal Critical Role of Protein STING

A little STING could go a long way in helping treat or even avoid autoimmune diseases such as arthritis, type 1 diabetes and multiple sclerosis, researchers report.

10 Sep 2013

Nanodiamonds Enable Direct Application of Chemotherapy to Brain Tumors

Researchers at UCLA’s Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

From University of California, Los Angeles 10 Sep 2013

Micromeritics Expert to Present at PDA Pharmaceutical Freeze Drying Conference in Dusseldorf, Germany

Micromeritics Scientist to present at the Parenteral Drug Association (PDA) Pharmaceutical Freeze Drying Conference taking place in Dusseldorf, Germany, September 24 – 25, 2013. Attendees to this conference includ...

From Micromeritics Instrument Corporation 9 Sep 2013

Virginia Tech Assistant Professor Develops New Flexible Microneedle Patch for Quicker Drug Delivery

An assistant professor with the Virginia Tech - Wake Forest School of Biomedical Engineering has developed a flexible microneedle patch that allows drugs to be delivered directly and fully through the skin. The new patch can quicken drug delivery time while cutting waste, and can likely minimize side-effects in some cases, notable in vaccinations and cancer therapy.

7 Sep 2013

New Nanotechnology Platform for Precise Eradication of Solid Tumors

ProScanRxPharma Inc. and Grafoid Inc announced today the formation of Calevia Inc., an entirely new cancer therapeutic nanotechnology platform for the precise targeting and thermal eradication of solid tumors.

6 Sep 2013

Scientists Develop Nano-Sized Form of Aspirin

Scientists are reporting development of a new form of aspirin — taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke — that could extend aspirin’s benefits to people who may not respond to the drug. Their advance toward coping with “aspirin resistance” appears in the journal ACS Nano.

From American Chemical Society 5 Sep 2013

Self-Powered Nanoparticles Target Newly Formed Microcracks in Bones

A novel method for finding and delivering healing drugs to newly formed microcracks in bones has been invented by a team of chemists and bioengineers at Penn State and Boston University. The method involves the targeted delivery of the drugs, directly to the cracks, on the backs of tiny self-powered nanoparticles.

5 Sep 2013

Tekmira Licensee, Spectrum, Launches Marqibo Cancer Treatment

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, disclosed that its licensee, Spectrum Pharmaceuticals, Inc., announced that it has launched Marqibo through its existing hematology sales force in the United States and has shipped the first commercial orders. Tekmira is entitled to royalty payments based on Marqibo's commercial sales.

5 Sep 2013

NanoViricides Seeks Orphan Drug Designation for DengueCide in the European Union

NanoViricides, Inc. (the "Company") announced today that the European associates of the consulting firm Cote´ Orphan Consulting, on behalf of NanoViricides, have submitted an Orphan Drug Application to the European Medicines Agency (EMA) for DengueCide™, a drug candidate for the treatment of dengue and dengue hemorrhagic fever.

From NanoViricides, Inc 4 Sep 2013